microdosing semaglutide for menopause GLP-1s: Benefits Management GLP-1 Microdosing During Menopause: Is

What the Evidence Shows and What It Does Not MedicalDaily Evidence Check Data source: Multiple peer-reviewed studies published 2025-2026, including British Journal of Pharmacology, Nature Reviews Endocrinology, and body composition literature on STEP and SURMOUNT trial data Key finding: Up to 40% of weight lost on high-efficacy GLP-1 drugs is lean body mass

A growing number of patients are asking a different question: are GLP-1 medications the best way to lose weight in 2026

In addition to their endothelial protective properties, GLP-1RAs have been shown to delay atherogenesis by improving VSMC dysfunction

Cannabinoid Receptors: Where They are and What They do